Literature DB >> 19699350

Prospective echocardiography assessment of pulmonary hypertension and its potential etiologies in children with sickle cell disease.

Niti Dham1, Gregory Ensing, Caterina Minniti, Andrew Campbell, Manuel Arteta, Sohail Rana, Deepika Darbari, Mehdi Nouraie, Onyinye Onyekwere, Malgorzata Lasota, Gregory J Kato, Mark T Gladwin, Oswaldo Castro, Victor Gordeuk, Craig Sable.   

Abstract

Pulmonary hypertension (PH) is associated with adverse outcomes in adults with sickle-cell disease (SCD), but its importance in children is less clear. The aim of this study was to define the incidence and causes of PH in pediatric patients with SCD. Children with SCD (n = 310) and matched controls (n = 54) were prospectively enrolled under basal conditions. Participants underwent echocardiography, pulse oximetry, 6-minute walk tests, and hematologic testing. Echocardiographic measures were compared between patients with SCD and control subjects before and after adjusting for hemoglobin. Correlations of echocardiographic and clinical parameters were determined. Tricuspid regurgitation velocity (TRV) was elevated compared to controls (2.28 vs 2.10 m/s, p <0.0001). Increased TRV was associated with left ventricular diastolic diameter, hemoglobin, and estimated left atrial pressure. TRV remained elevated when controlling for left ventricular diameter and left atrial pressure. Echocardiographically derived pulmonary resistance was not significantly different between patients with SCD and controls, although it was elevated in the SCD subgroup with elevated TRV. When controlling for hemoglobin, TRV was no longer statistically different, but pulmonary insufficiency velocity, septal wall thickness, and estimated pulmonary resistance were statistically higher. TRV, pulmonary insufficiency end-diastolic velocity, and markers of increased cardiac output were correlated with indicators of adverse functional status, including history of acute chest syndrome, stroke, transfusions, and 6-minute walk distance. In conclusion, children with SCD had mildly increased TRV that was correlated with increased cardiac output and left ventricular filling pressures. Hemoglobin-adjusted analysis also suggested a contribution of primary vascular changes.

Entities:  

Mesh:

Year:  2009        PMID: 19699350      PMCID: PMC3197734          DOI: 10.1016/j.amjcard.2009.04.034

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  30 in total

1.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.

Authors:  Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart
Journal:  J Am Soc Echocardiogr       Date:  2005-12       Impact factor: 5.251

2.  The outcomes of sickle cell disease in adulthood are clear, but the origins and progression of sickle cell anemia-induced problems in the heart and lung in childhood are not.

Authors:  Jessica H Boyd; Robert C Strunk; Wayne J Morgan
Journal:  J Pediatr       Date:  2006-07       Impact factor: 4.406

3.  Guidelines and standards for performance of a pediatric echocardiogram: a report from the Task Force of the Pediatric Council of the American Society of Echocardiography.

Authors:  Wyman W Lai; Tal Geva; Girish S Shirali; Peter C Frommelt; Richard A Humes; Michael M Brook; Ricardo H Pignatelli; Jack Rychik
Journal:  J Am Soc Echocardiogr       Date:  2006-12       Impact factor: 5.251

4.  Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease.

Authors:  Vandana Sachdev; Roberto F Machado; Yukitaka Shizukuda; Yesoda N Rao; Stanislav Sidenko; Inez Ernst; Marilyn St Peter; Wynona A Coles; Douglas R Rosing; William C Blackwelder; Oswaldo Castro; Gregory J Kato; Mark T Gladwin
Journal:  J Am Coll Cardiol       Date:  2007-01-16       Impact factor: 24.094

5.  Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease.

Authors:  Gregory J Kato; Vicki McGowan; Roberto F Machado; Jane A Little; James Taylor; Claudia R Morris; James S Nichols; Xunde Wang; Mirjana Poljakovic; Sidney M Morris; Mark T Gladwin
Journal:  Blood       Date:  2005-11-15       Impact factor: 22.113

6.  Right ventricular and pulmonary function in sickle cell disease patients with pulmonary hypertension.

Authors:  Ferit Akgül; Fatih Yalçin; Cenk Babayiğit; Ergün Seyfeli; Tunzale Seydaliyeva; Edip Gali
Journal:  Pediatr Cardiol       Date:  2006-07-11       Impact factor: 1.655

7.  Evaluation of left ventricular diastolic function in pediatric sickle cell disease patients.

Authors:  Mark V Zilberman; Wei Du; Srikant Das; Sharada A Sarnaik
Journal:  Am J Hematol       Date:  2007-06       Impact factor: 10.047

8.  High prevalence of pulmonary hypertension in children with sickle cell disease.

Authors:  Stephen C Nelson; Beverly B Adade; Elizabeth A McDonough; Kristin L Moquist; Jane M Hennessy
Journal:  J Pediatr Hematol Oncol       Date:  2007-05       Impact factor: 1.289

9.  Elevation of tricuspid regurgitant jet velocity, a marker for pulmonary hypertension in children with sickle cell disease.

Authors:  Steven J Ambrusko; Sriya Gunawardena; Allison Sakara; Beth Windsor; Lizabeth Lanford; Peter Michelson; Lakshmanan Krishnamurti
Journal:  Pediatr Blood Cancer       Date:  2006-12       Impact factor: 3.167

10.  Assessment of pulmonary vascular resistance by Doppler echocardiography in patients with pulmonary arterial hypertension.

Authors:  Nedim Selimovic; Bengt Rundqvist; Claes-Hakan Bergh; Bert Andersson; Sofia Petersson; Lena Johansson; Odd Bech-Hanssen
Journal:  J Heart Lung Transplant       Date:  2007-09       Impact factor: 10.247

View more
  25 in total

Review 1.  Update on pulmonary hypertension 2009.

Authors:  Mark T Gladwin; Hossein-Ardeschir Ghofrani
Journal:  Am J Respir Crit Care Med       Date:  2010-05-15       Impact factor: 21.405

2.  Vascular risk assessment in patients with sickle cell disease.

Authors:  Claudia R Morris
Journal:  Haematologica       Date:  2011-01       Impact factor: 9.941

Review 3.  Cardiovascular abnormalities in sickle cell disease.

Authors:  Mark T Gladwin; Vandana Sachdev
Journal:  J Am Coll Cardiol       Date:  2012-03-27       Impact factor: 24.094

4.  Prediction of fetal hemoglobin in sickle cell anemia using an ensemble of genetic risk prediction models.

Authors:  Jacqueline N Milton; Victor R Gordeuk; James G Taylor; Mark T Gladwin; Martin H Steinberg; Paola Sebastiani
Journal:  Circ Cardiovasc Genet       Date:  2014-03-01

Review 5.  Recent progress in understanding pediatric pulmonary hypertension.

Authors:  Steven H Abman; D Dunbar Ivy
Journal:  Curr Opin Pediatr       Date:  2011-06       Impact factor: 2.856

6.  Hemodynamic characteristics and predictors of pulmonary hypertension in patients with sickle cell disease.

Authors:  Melissa C Caughey; Alan L Hinderliter; Susan K Jones; Sanjeev P Shah; Kenneth I Ataga
Journal:  Am J Cardiol       Date:  2012-02-15       Impact factor: 2.778

Review 7.  Intravascular hemolysis and the pathophysiology of sickle cell disease.

Authors:  Gregory J Kato; Martin H Steinberg; Mark T Gladwin
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

8.  Biochemical surrogate markers of hemolysis do not correlate with directly measured erythrocyte survival in sickle cell anemia.

Authors:  Charles T Quinn; Eric P Smith; Shahriar Arbabi; Paramjit K Khera; Christopher J Lindsell; Omar Niss; Clinton H Joiner; Robert S Franco; Robert M Cohen
Journal:  Am J Hematol       Date:  2016-11-08       Impact factor: 10.047

9.  Tricuspid regurgitation velocity and other biomarkers of mortality in children, adolescents and young adults with sickle cell disease in the United States: The PUSH study.

Authors:  Mehdi Nouraie; Deepika S Darbari; Sohail Rana; Caterina P Minniti; Oswaldo L Castro; Lori Luchtman-Jones; Craig Sable; Niti Dham; Gregory J Kato; Mark T Gladwin; Gregory Ensing; Manuel Arteta; Andrew Campbell; James G Taylor; Sergei Nekhai; Victor R Gordeuk
Journal:  Am J Hematol       Date:  2020-04-21       Impact factor: 10.047

Review 10.  Differences in the clinical and genotypic presentation of sickle cell disease around the world.

Authors:  Santosh L Saraf; Robert E Molokie; Mehdi Nouraie; Craig A Sable; Lori Luchtman-Jones; Gregory J Ensing; Andrew D Campbell; Sohail R Rana; Xiao M Niu; Roberto F Machado; Mark T Gladwin; Victor R Gordeuk
Journal:  Paediatr Respir Rev       Date:  2013-11-15       Impact factor: 2.726

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.